MedinCell S.A. (MEDCL.PA)
| Previous close | 13.64 |
| Open | 13.60 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 13.50 - 14.06 |
| 52-week range | 5.25 - 17.50 |
| Volume | |
| Avg. volume | 121,895 |
| Market cap | 396.17M |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.86 |
| Earnings date | 25 Jun 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.10 |
Simply Wall St.Euronext Paris Growth Companies With High Insider Ownership And Up To 42% Revenue Growth
As political uncertainty and economic challenges continue to shape the landscape across European markets, France has not been immune to these pressures. In this context, identifying growth companies with high insider ownership on the Euronext Paris can offer investors potential resilience and alignment of interests between shareholders and management, especially in sectors demonstrating up to 42% revenue growth.
- Simply Wall St.
Three High Insider Ownership Growth Companies On Euronext Paris With Up To 101% Earnings Growth
Amidst a backdrop of political uncertainty and fluctuating market conditions across Europe, France's market has particularly felt the impact, with significant movements in bond yields and equity indices. In such an environment, exploring growth companies with high insider ownership on Euronext Paris could offer investors a unique blend of potential resilience and growth, given that high insider ownership often aligns company leadership closely with shareholder interests.
- Simply Wall St.
Lectra And 2 Other Euronext Paris Growth Stocks With High Insider Ownership
Amidst a backdrop of political uncertainty and fluctuating market conditions across Europe, France's equity landscape has not been immune to the pressures seen region-wide. In such a climate, growth companies with high insider ownership, like Lectra, can offer investors a unique blend of stability and potential resilience due to their closely aligned management interests.
